Back to Legal & General Group Plc Legal & General Group Plc

SMMT

18 quarters

Position history for Legal & General Group PlcLegal & General Group Plc's holdings in Summit Therapeutics Inc.

Yes. Legal & General Group holds 18,247 shares of SMMT (Summit Therapeutics), worth $265,859, as of its Q2 2026 13F filing. It reduced the position by 13,645 shares (-42.8%) from Q1 2026. Legal & General Group has held SMMT since Q2 2023, across 13 quarterly 13F filings.

Current Value

$265,859

Current Shares

18,247

Total Value Change

+$247,859

Total Shares Change

+15,868

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
18,247
-42.8%
$265,8590.0%$14.57
0
2026-Q1
Increased
31,892
+16.6%
$604,6730.0%$18.96
28
2025-Q4
Increased
27,359
+3.1%
$478,5090.0%$17.49
25
2025-Q3
Increased
26,536
+0.6%
$548,2340.0%$20.66
24
2025-Q2
Increased
26,367
+33.8%
$561,0900.0%$21.28
31
2025-Q1
Increased
19,705
+95.9%
$380,1090.0%$19.29
38
2024-Q4
Increased
10,061
+3.5%
$179,5380.0%$17.85
16
2024-Q3
Decreased
9,719
-48.7%
$212,7490.0%$20.89
0
2024-Q2
Decreased
18,931
-83.9%
$147,5670.0%$7.80
0
2024-Q1
Decreased
117,618
-1.2%
$486,9390.0%$4.14
0
2023-Q4
Increased
119,004
+0.8%
$311,0230.0%$2.61
24
2023-Q3
Increased
118,095
+6.8%
$220,8380.0%$1.87
25
2023-Q2
New
110,615
-
$277,6430.0%$2.51
32
2022-Q2
Exited
0
-100.0%
$00.0%$0.97
0
2022-Q1
Unchanged
2,770
0.0%
$7,0000.0%$2.58
0
2021-Q4
Unchanged
2,770
0.0%
$7,0000.0%$2.55
0
2021-Q3
Increased
2,770
+16.4%
$14,0000.0%$5.01
14
2021-Q2
New
2,379
-
$18,0000.0%$7.46
28

Other major holders of SMMT: Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used